Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 31;24(1):638.
doi: 10.1186/s12877-024-05216-6.

Sarcopenic obesity and pre-sarcopenia contribute to frailty in community-dwelling Italian older people: data from the FRASNET study

Affiliations

Sarcopenic obesity and pre-sarcopenia contribute to frailty in community-dwelling Italian older people: data from the FRASNET study

Sarah Damanti et al. BMC Geriatr. .

Abstract

Background: The ageing process is characterized by a change of body composition with an increase of fat mass and a reduction of muscle mass. Above a certain threshold these alterations configure a condition named sarcopenic obesity (SO). SO is associated with physical frailty in Asian and Brazilian populations. SO impacts on physical frailty in other ethnic groups but its influence on general frailty which is multidimensional and includes cognitive, social and physical factors, remain insufficiently explored in the Italian population.

Methods: Frailty was measured in community dwelling Italian older adults enrolled in the FRASNET study with the frailty index (FI). The FI quantifies frailty as the ratio of the number of present health deficits to the total number of health deficits considered. Regression analyses were performed to assess the association between body composition categories and frailty. Classification and regression tree models were run to evaluate the frailty predictors.

Results: One Thousand One Hundred Fourteen participants of the FRASNET study were included in the present analysis. The sample was composed for the 60.5% by females and its median age was 72 years. The median FI score was 0.11 (IQR 0.07-0.20); 234 individuals (21%) were frail (FI ≥ 0.25). SO (B 0.074, 95% C.I. 0.05-0.1, p < 0.001) and pre-sarcopenia (without obesity B 0.03, 95% C.I, 0.007-0.044, p < 0.001, with obesity B 0.11, 95% C.I. 0.05-0.16, p < 0.001) were associated with frailty. Fat mass percentage predicted frailty in people aged 65-70 years whereas, muscle strength predicted general frailty in people aged 70-81 years.

Conclusion: Pre-sarcopenia and SO represent potentially treatable predictors of frailty.

Keywords: Body composition; Frailty index; Sarcopenia; Sarcopenic obesity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Body composition categories in the study population. Robust no obesity: 425 individuals (38.2%), robust with obesity 28 individuals (2.5%), reduced muscle mass normal strength no obesity 138 individuals (12.4%), reduced muscle mass normal strength with obesity 195 individuals (17.5%), presarcopenia no obesity 173 individuals (15.5%), presarcopenia with obesity 18 individuals (1.6%), sarcopenia no obesity 51 individuals (4.6%), sarcopenia with obesity 86 individuals (7.7%)
Fig. 2
Fig. 2
Regression tree of the predictors of frailty measured through the frailty index

References

    1. Ponti F, Santoro A, Mercatelli D, Gasperini C, Conte M, Martucci M, et al. Aging and Imaging Assessment of body composition: from Fat to facts. Front Endocrinol (Lausanne). 2020;10:861. 10.3389/fendo.2019.00861. 10.3389/fendo.2019.00861 - DOI - PMC - PubMed
    1. Haffner SM. Abdominal adiposity and cardiometabolic risk: do we have all the answers? Am J Med. 2007;120(9 Suppl 1):S10–6. discussion S16-7. 10.1016/j.amjmed.2007.06.006 - DOI - PubMed
    1. Koster A, Patel KV, Visser M, Van Eijk JTM, Kanaya AM, De Rekeneire N, et al. Joint effects of adiposity and physical activity on incident mobility limitation in older adults. J Am Geriatr Soc. 2008;56:636–43. 10.1111/j.1532-5415.2007.01632.x. 10.1111/j.1532-5415.2007.01632.x - DOI - PubMed
    1. Evans WJ, Guralnik J, Cawthon P, Appleby J, Landi F, Clarke L, et al. Sarcopenia: no consensus, no diagnostic criteria, and no approved indication-how did we get here? Geroscience. 2024;46(1):183–90. 10.1007/s11357-023-01016-9 - DOI - PMC - PubMed
    1. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31. 10.1093/ageing/afy169 - DOI - PMC - PubMed

LinkOut - more resources